LAB
NASDAQ · Life Sciences Tools & Services
Standard Biotools Inc
$0.94
+0.01 (+0.73%)
Analyst Consensus
Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+3,197.7% upside
Low Target
$24.11
Average Target
$30.85
High Target
$37.88
Current Price
$0.94
Current
$0.94
$0.94
Target
$30.85
$30.85
$24.11
$30.85 avg
$37.88
Scenario Analysis
Bear Case
$24.11
2,477.2%
Low target
Base Case
$30.85
+3,197.7%
Avg target
Bull Case
$37.88
+3,949.2%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$1.72
-45.6% from high
52-Week Low
$0.87
+7.5% from low
Target vs 52W High
$30.85
+1,693.6% vs high
Next Earnings Report
May 12, 2026
1d
tomorrow
EPS Est: $-0.06
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 34 | 88% | $369.21 | -20.6% |
| DHR | Strong Buy | 30 | 87% | $158.11 | -7.6% |
| WAT | Buy | 28 | 57% | $189.60 | -46.6% |
| A | Strong Buy | 28 | 79% | $64.69 | -44.0% |
| IQV | Strong Buy | 31 | 87% | $82.96 | -53.6% |
| MTD | Hold | 21 | 48% | $170.43 | -84.8% |
| WST | Strong Buy | 23 | 78% | $136.24 | -58.2% |
| ILMN | Hold | 28 | 54% | $169.36 | +19.4% |